ATEX$92.33

Assuming this is a spectrum licensing/telecom infrastructure business, revenue has grown strongly over the last five years, rising from 1.1 to 6.5, though the pace clearly decelerated in FY2026 and TTM growth slowed further versus earlier hypergrowth years. Gross margin stays near 100%, but operating margins remain deeply negative because SG&A and R&D are still far above revenue, so top-line growth has not translated into operating profitability. Reported net income turned sharply positive only because of a very large gain on sale of assets, which also lifted pretax income; excluding that item, underlying earnings remain negative. Free cash flow is volatile but improved in the latest periods, while repeated losses and reliance on one-offs remain the main red flags.

Anterix shows a strong liquidity position, with current assets of $153.1 million versus current liabilities of $31.6 million and working capital of $121.5 million. Cash and equivalents rose to $116.0 million, while debt remains minimal at $4.1 million, leaving net cash of $111.9 million. Total assets expanded to $497.9 million and shareholders’ equity improved to $285.8 million after a weaker FY2025, which is a positive sign. However, the balance sheet is heavily shaped by intangible assets of $310.3 million and a large long-term unearned revenue balance of $160.6 million, while retained earnings remain deeply negative at $302.1 million and tangible book value is still negative. Overall, solvency is solid, but asset quality is mixed and equity remains structurally weak on a tangible basis.

Cash generation has been highly uneven, with operating cash flow swinging from 17.9 in FY2022 to -27.3 in FY2023, then 42.0 in FY2024, -29.3 in FY2025, and 5.5 in FY2026; TTM improved to 10.7. The main driver is large working-capital movement, especially unearned revenue, which makes the quality of CFO less stable than the headline numbers suggest. Capex is minimal, so reported free cash flow is generally close to CFO, but sustainability remains mixed because FY2025 was negative and TTM is only modestly positive at 10.6. Investing cash flow is heavily supported by divestitures, while buybacks have continued and share issuance adds some offset. Overall, cash generation is improving but still inconsistent and somewhat dependent on non-core items.

Anterix shows strong short-term liquidity, with the current ratio and quick ratio both remaining well above 1x and improving overall from the low point in FY 2023. Leverage looks modest and even lighter recently, with debt-to-equity trending down to very low levels, suggesting limited balance sheet strain. Efficiency is a clear कमजोरी: asset turnover stays around 0.01–0.02, indicating that assets are generating little revenue relative to their size. Profitability is mixed. ROE turned strongly positive in FY 2026 and remains positive in the current reading, but ROA, ROIC, and ROCE are still negative, showing weak underlying capital productivity. Overall, the balance sheet is sound, but operating efficiency and returns remain uneven.

The pattern shifts from a long period of minimal sales and negative EPS to a pronounced forward step-up, with revenue moving from 0.01B USD to 20.83B USD before easing to 14.71B USD. That implies a sharp commercial inflection followed by some normalization rather than smooth compounding. Revenue growth is highly uneven, with a major surge in the middle of the outlook and then a pullback, which is more consistent with a one-time ramp than steady acceleration. EPS turns strongly positive and grows modestly from 4.83 to 5.23, broadly in line with the revenue reset and suggesting improving margins. Analyst sentiment is constructive: Buy with 3 analysts, a 86 to 130 USD target range, and only a mild shift toward more Hold views over time.